New Zealand markets open in 6 hours 5 minutes

RedHill Biopharma Ltd. (2RH0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.3255+0.0180 (+5.85%)
At close: 09:01PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 11.03M
Enterprise value 6.93M
Trailing P/E 0.09
Forward P/E 1.25k
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.35
Price/book (mrq)5.37
Enterprise value/revenue 1.14
Enterprise value/EBITDA 0.28

Trading information

Stock price history

Beta (5Y monthly) 3.56
52-week change 3-70.41%
S&P500 52-week change 322.55%
52-week high 33.5800
52-week low 30.2440
50-day moving average 30.3689
200-day moving average 30.5913

Share statistics

Avg vol (3-month) 3548
Avg vol (10-day) 3N/A
Shares outstanding 531.87M
Implied shares outstanding 611.74M
Float 86.85B
% held by insiders 10.00%
% held by institutions 113.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 323 Mar 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 366.25%
Operating margin (ttm)-1,060.79%

Management effectiveness

Return on assets (ttm)-15.71%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)6.53M
Revenue per share (ttm)1.01
Quarterly revenue growth (yoy)-95.60%
Gross profit (ttm)N/A
EBITDA -22.15M
Net income avi to common (ttm)23.92M
Diluted EPS (ttm)3.7400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.57M
Total cash per share (mrq)0
Total debt (mrq)1.17M
Total debt/equity (mrq)56.69%
Current ratio (mrq)0.84
Book value per share (mrq)0.10

Cash flow statement

Operating cash flow (ttm)-35.82M
Levered free cash flow (ttm)-18.23M